Table 4. Prevalence of T1762/A1764 mutations in various forms of liver disease.

Group	Prevalence of genotype		Mutations at T1762/A1764	Total
Group 1 (n = 3) (HBV DNA<2000 IU/ml, ALT<ULN)	A	1 (33.3%)	0	0%
	D	2 (66.7%)	0
Group 2 (n = 15) (HBV DNA>2000 IU/ml, ALT>ULN)	A	6 (40%)	3 (20%)	9 (60%)
	C	3 (20%)	3 (20%)
	D	6 (40%)	3 (20%)
Group 3 (n = 20) Liver Cirrhosis and Hepatocellular Carcinoma	A	4 (20%)	2 (10%)	18 (90%)
	C	13 (65%)	13 (65%)
	D	3 (15%)	3 (15%)
Total N = 38				27 (71.05%)